Absci Corp (ABSI) stock

ABSINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30

$8.45−0.69 (-7.50%)

Close on Nov 13, 2026Market cap $1.45BP/E –Yield –

Absci operating margin

Operating margin is operating income as a percentage of revenue.

Absci's operating margin for the twelve months ending Sep 30, 2026 was -8812.3%. For fiscal 2025 it was -4297.0%, against -2401.6% the year before. The highest annual figure on record is -278.3% in fiscal 2020.

Annual operating margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-4297.0%	−1895.4
FY2024	Dec 31, 2024	-2401.6%	−381.4
FY2023	Dec 31, 2023	-2020.2%	−162.7
FY2022	Dec 31, 2022	-1857.5%	−284.1
FY2021	Dec 31, 2021	-1573.4%	−1295.1
FY2020	Dec 31, 2020	-278.3%	–

Quarterly operating margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	-11511.2%	−3533.9
Q2 FY2026	Jun 30, 2026	-10741.5%	−5447.6
Q1 FY2026	Mar 31, 2026	-14347.0%	−11995.1
Q4 FY2025	Dec 31, 2025	-4775.5%	−298.2
Q3 FY2025	Sep 30, 2025	-7977.2%	−6278.5
Q2 FY2025	Jun 30, 2025	-5293.9%	−3189.9
Q1 FY2025	Mar 31, 2025	-2351.9%	+264.8
Q4 FY2024	Dec 31, 2024	-4477.3%	+2841.9
Q3 FY2024	Sep 30, 2024	-1698.7%	+1433.4
Q2 FY2024	Jun 30, 2024	-2104.0%	−827.3
Q1 FY2024	Mar 31, 2024	-2616.7%	−687.2
Q4 FY2023	Dec 31, 2023	-7319.2%	−5964.5
Q3 FY2023	Sep 30, 2023	-3132.1%	−1951.6
Q2 FY2023	Jun 30, 2023	-1276.7%	+1606.2
Q1 FY2023	Mar 31, 2023	-1929.5%	+1587.4
Q4 FY2022	Dec 31, 2022	-1354.7%	+453.5
Q3 FY2022	Sep 30, 2022	-1180.5%	+193.2
Q2 FY2022	Jun 30, 2022	-2882.9%	−590.1
Q1 FY2022	Mar 31, 2022	-3516.8%	−2468.1
Q4 FY2021	Dec 31, 2021	-1808.3%	−1638.4
Q3 FY2021	Sep 30, 2021	-1373.7%	−1006.5
Q2 FY2021	Jun 30, 2021	-2292.9%	−1793.9
Q1 FY2021	Mar 31, 2021	-1048.7%	–
Q4 FY2020	Dec 31, 2020	-169.8%	–
Q3 FY2020	Sep 30, 2020	-367.2%	–
Q2 FY2020	Jun 30, 2020	-498.9%	–